The best site about Microbiology Synthetic Media
Buy Now >>
Buy Now >>
Buy Now >>
Microbiology Synthetic Media - Best News
Pacific Biosciences of California ( PACB ) Q4 2013 Earnings Call February 4, 2014 4:30 PM ET
Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Pacific Biosciences Fourth Quarter Fiscal Year 2013 Earnings Conference Call. [Operator Instructions]
I would now like to turn the conference to our host, Ms. Trevin Rard. Ma'am, you may begin.
Thank you. Good afternoon, and welcome to the Pacific Biosciences Fourth Quarter and Fiscal Year 2013 Conference Call.
Earlier today, we issued a press release outlining the financial results we'll be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com, or alternatively, as furnished on Form 8-K available on Securities and Exchange Commission website at www.sec.gov.
With me today are Mike Hunkapiller, our Chairman and Chief Executive Officer; Susan Barnes, our Chief Financial Officer; and Ben Gong, our Vice President of Finance and Treasurer.
Microbiology Synthetic Media - Recent Articles
Microbial Culture Media
The micro-organism require a base medium for their growth andit is called as culture media.
Nutrient media contains the substances that are used by organism synthesis of food, growth and survival.It fulfill all the nutritional requirements of the micro-organism.The nutrient media consist of water as the important ingredient plus organic and inorganic components,growth factors, indicator dyes and agar-agar as a solidifying agent.
Microbial culture media is basically of two types that is non-living and living media and further on the basis of ingredients present the culture media are sub-divided.Nature of Microbial culture media are shown in the following figure.
a ) Natural media - The media that contains natural substances like milk,blood,potato etc are called natural media.
b) Semi-synthetic media...
C16G2 is a synthetic peptide derived from C3 Jian's proprietary, pheromone signaling platform technology referred to as STAMPS (Specifically Targeted Antimicrobial Peptides). C16G2 The double-blind Phase 1 clinical trial included a dose escalation